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        Lyme arthritis results from infection with a tick-
borne spirochete,   Borrelia burgdorferi   (  1  ). Spiro-
chetes are deposited into the skin when   Ixodes 
scapularis   feed on mice or humans.   B. burgdorferi   
replicate in the dermis, and then disseminate to 
distant cutaneous sites and other organs, includ-
ing the joints (  2  ). Clinical manifestations of 
Lyme disease may involve a characteristic skin 
rash called   erythema migrans  , arthritis, carditis, or 
neurological symptoms (  3, 4  ). Lyme arthritis 
occurs in a substantial number of untreated pa-
tients (  1  ), often several weeks to months after 
the tick bite, and is associated with spirochete 
invasion of the joints (  3  ). In most cases, antibi-
otic therapy is curative; however, some patients 
develop a form of antibiotic-resistant arthritis 
that is thought to be unrelated to persistent 
infection (  5  ). 
  C3H/HeN mice infected with   B. burgdorferi   
develop joint swelling that partially mimics hu-
man disease and has been helpful in understand-
ing the pathogenesis of Lyme arthritis (  6  –  9  ). 
Intradermally inoculated spirochetes reside in 
the mouse skin for     1 wk, after which they dis-
seminate to many tissues. Arthritis begins to de-
velop at     10 d and is prominent at 2 or 3 wk 
(  2, 10  ). At 4 wk, the disease may begin to re-
gress, and by 8 wk the arthritis has resolved 
(  2, 6, 7, 11  –  13  ). The presence of   B. burgdorferi   
in mouse joints, and the innate and adaptive host 
responses to the pathogen, contributes to the 
development of infl  ammation (  1  ). Spirochete 
genes are also implicated in mouse Lyme arthri-
tis, as   B. burgdorferi   lacking certain plasmids are 
less arthritogenic (  14  ). Indeed,   B. burgdorferi Arp   
is expressed in many tissues during infection, and 
antisera against Arp can attenuate mouse Lyme 
arthritis (  15, 16  ). Specifi  c spirochete antigens 
that are selectively induced in the joints and 
causally associated with the genesis of arthritis 
have, however, not yet been identifi  ed. 
  The preferential up-regulation of specifi  c 
  B. burgdorferi   genes throughout the spirochete 
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  Lyme arthritis results from colonization of joints by   Borrelia burgdorferi   and the ensuing 
host response. Using gene array  –  based differential analysis of   B. burgdorferi   gene 
expression and quantitative reverse trancription-polymerase chain reaction, we identifi  ed two 
paralogous spirochete genes,   bmpA   and   bmpB,   that are preferentially up-regulated in 
mouse joints compared with other organs. Transfer of affi  nity-purifi  ed antibodies against 
either BmpA or BmpB into   B. burgdorferi    –  infected mice selectively reduced spirochete 
numbers and infl  ammation in the joints.   B. burgdorferi   lacking   bmpA/B   were therefore 
generated to further explore the role of these proteins in the pathogenesis of Lyme disease. 
  B. burgdorferi   lacking   bmpA/B   were infectious in mice, but unable to persist in the joints, 
and they failed to induce severe arthritis. Complementation of the mutant spirochetes with 
a wild-type copy of the   bmpA   and   bmpB   genes partially restored the original phenotype. 
These data delineate a role for differentially produced   B. burgdorferi   antigens in spirochete 
colonization of mouse joints, and suggest new strategies for the treatment of Lyme arthritis. 2 of 9 ROLE OF   BORRELIA   BMPA/B PROTEINS IN LYME ARTHRITIS | Pal et al.
also minimal in spirochetes isolated from infected ticks; their 
expression levels were     8  –  10-fold lower than the corre-
sponding levels in spirochetes isolated from joints at day 15. As 
  bmpA   and   bmpB   showed the greatest degree of selective up-
regulation in joints, these gene products were further examined 
to explore the paradigm that tissue-specifi  c gene expression 
contributes to arthritis. 
  Antibodies against BmpA or BmpB interfere with 
  B. burgdorferi   persistence most dramatically in joints 
  To explore the physiological relevance of the joint-specifi  c 
up-regulation of   bmpA   and   bmpB,   we assessed whether specifi  c 
antibodies were capable of interfering with   B. burgdorferi   per-
sistence in the joints. To achieve this goal, we produced re-
combinant BmpA and BmpB in   Escherichia coli   and generated 
antisera against the individual proteins in rabbits. As antisera 
against BmpA may cross-react with BmpB, or vice versa (  28  ), 
monospecifi  c BmpA and BmpB antibodies were isolated by 
affi   nity purifi  cation, as detailed in the Materials and methods. 
We then characterized the specifi  city of the purifi  ed BmpA or 
BmpB antibodies and their capacity to bind to the spirochete 
surface. Immunoblots demonstrated substantial binding of pu-
rifi  ed BmpA or BmpB antibodies to their respective proteins, 
with minimal cross-reactivity (  Fig. 2 A  )  .   I  n addition  ,   immuno-
fl  uorescence microscopy showed that both of the Bmp anti-
bodies were able to bind to the surface of unfi  xed cultured 
  B. burgdorferi   (  Fig. 2 B  ) and had partial borreliacidal activity 
in vitro (  Fig. 2 C  ). 
  We next performed passive immunization studies to assess 
whether purifi  ed BmpA or BmpB antibodies interfered with 
selective   B. burgdorferi   persistence in joints. To accomplish 
life cycle, both in the vector and mammalian host, plays an 
important role in pathogen survival (  17  –  19  ). It is likely that 
the diverse metabolic or immune microenvironments within 
mammalian tissues may infl  uence the ability of   B. burgdorferi   
to persist in diff  erent organs (  20  –  22  ). We determined, there-
fore, whether particular   B. burgdorferi   genes are selectively ex-
pressed in mouse joints, and if the gene products contribute 
to spirochete colonization of the joints and the development 
of arthritis. Characterization of microbial ligands that are ex-
pressed in a tissue-specifi  c manner is critical for understand-
ing the pathogenesis of complex infectious diseases. 
    RESULTS   
  Identifi  cation of   B. burgdorferi   genes up-regulated 
in mouse joints 
  We identifi  ed a subset of   B. burgdorferi   genes that are prefer-
entially up-regulated in mouse joints using a microarray-based 
analysis to compare spirochete transcriptomes from diff  erent 
tissues. The diff  erential expression analysis using a custom-
amplifi  ed library (DECAL) technique (  22, 23  ) specifi  cally 
amplifi  ed spirochete mRNAs from infected skin, joints, heart, 
and bladder. To accomplish this, C3H/HeN mice were chal-
lenged with   B. burgdorferi  . At day 15, when arthritis was evi-
dent (  14, 24  ) and was refl  ected by swelling of the tibio  tarsal 
joints, total RNA was isolated from the skin, joints, heart, and 
bladder tissue.   B. burgdorferi    –  specifi  c mRNAs were selected and 
amplifi  ed using the DECAL technique and hybridized onto a 
  B. burgdorferi   genomic array, as detailed in the Materials and 
methods. Analysis of array data revealed that the expression of 
  B. burgdorferi   genes varied in diff  erent host tissues, and that 
the   B. burgdorferi bmpA/B   gene operon displayed the most sig-
nifi  cant up-regulation in joints. 
  The temporal expression of   bmpA/B   coincides with  
B. burgdorferi   infection of mouse joints and the induction 
of Lyme arthritis 
  We used the gene array data as a guide to perform more de-
tailed quantitative RT-PCR (qRT-PCR) analyses on the genes 
of interest. The   B. burgdorferi bmp   gene family has four paralogous 
members,   bmpA  ,   bmpB  ,   bmpC  , and   bmpD   (  25  ), where   bmpA   
and   bmpB   are on a bicistronic operon and may be controlled by 
a common promoter (  26, 27  ). We assessed the independent 
expression of each   bmp   gene throughout the fi  rst few weeks of 
  B. burgdorferi   infection in multiple tissues using gene-specifi  c 
qRT-PCR analysis. Groups of C3H/HeN mice were infected 
with   B. burgdorferi  , and tissues were isolated at 6, 9, 12, and 15 d. 
Isolated mRNA, without the DECAL enrichment, was con-
verted to cDNA and subjected to qRT-PCR to measure 
the individual   B. burgdorferi bmp   transcripts. Expression of   bmpA   
and   bmpB   in joints was dramatically and selectively up-regulated 
at 12 and 15 d compared with the skin, heart, and bladder 
(  Fig. 1  ).     bmpC   and   bmpD   expression showed no diff  erences 
between joint or other tissues and remained unchanged in the 
joints at 12 and 15 d; at earlier time points, spirochetes were 
not readily detectable in the joints, heart, or bladder (unpublished 
data). Furthermore, expression of both   bmpA   and   bmpB   was 
    Figure 1.         Joint-specifi  c up-regulation of   B. burgdorferi       bmpA and 
  bmpB   in infected mice.   The relative expression levels of   bmpA   (black 
bar) and   bmpB   (gray bar) are represented as copies of   bmp   transcript  per 
1,000 copies of   fl  aB   transcript. Total RNA was isolated from multiple tis-
sues of   B. burgdorferi    –  infected mice (10 mice/group) and converted to 
cDNA for measuring   bmp   transcripts using qPCR 12 and 15 d after chal-
lenge. Bars represent the mean   ±   the SEM from three independent experi-
ments. The transcript levels in joints were signifi  cantly higher than those 
in skin, heart, or bladder tissue.   n   =  3.  P   <   0.01 – 0.001.   JEM 
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we determined whether BmpA or BmpB antibodies infl  uenced 
disease. Development of joint swelling in   B. burgdorferi    –  in-
fected mice immunized with glutathione   S  -transferase (GST) 
antisera was signifi  cantly higher (1.36   ±   0.25 mm; P   <   0.02) than 
in groups of mice administered either BmpA (0.47   ±   0.13) or 
BmpB (0.65   ±   0.1) antibodies, suggesting a role for these 
proteins in the genesis of arthritis. 
    bmpA/B-  defi  cient   B. burgdorferi   persist poorly in joints 
and fail to induce arthritis 
  To directly study the importance of BmpA and BmpB in the 
spirochete persistence within joints, we created   bmpA/B  -defi  -
cient (  bmpA/B         )   B. burgdorferi  . The mutant was constructed by 
exchanging a DNA fragment within the   bmpAB   gene with a 
kanamycin-resistance cassette via homologous recombination 
(  Fig. 4 A  ).   A suicide plasmid for recombination in the intended 
chromosomal locus was constructed and transformed into 
  B. burgdorferi  , and transformants were screened as detailed in the 
Materials and methods. PCR analysis indicated that the anti-
biotic cassette was appropriately inserted into the intended chro-
mosomal locus and that the plasmid profi  le of the mutant 
spirochetes was similar to that of the wild-type organisms (un-
published data). RT-PCR showed that   bmpA   or   bmpB   mRNA 
was absent in the mutant, and, as expected, the mutant expressed 
both   bmpC   and   bmpD   mRNA (  Fig. 4 B  ). In addition, qRT-
PCR showed that both wild-type spirochetes and   bmpA/B          
  B. burgdorferi   produced similar levels of transcripts expressed 
this, groups of C3H/HeN mice (15 animals/group) were in-
fected with   B. burgdorferi  , and 3 d after spirochete challenge, 
mice were administered 100   μ  l of BmpA, BmpB, or control anti-
bodies  .   Skin, bladder, heart, and joints were collected on day 
12, 15, and 18.   B. burgdorferi   levels in each tissue were measured 
by qPCR. The passive transfer of either of the Bmp antibodies 
dramatically reduced   B. burgdorferi   levels in the joints, and 
to a lesser extent in skin, but not in other tissues, such as heart 
and bladder, at all time points. The data from days 15 and 18 
are presented in   Fig. 3  .   Because Lyme arthritis has been directly 
attributed to the presence of   B. burgdorferi   in joint tissue (  1  ), 
    Figure 2.         Characterization of affi  nity-purifi  ed BmpA and BmpB 
antibodies  . (A) 1 ng of recombinant Bmp proteins (rBmpA and rBmpB) 
was probed with either affi  nity-purifi  ed BmpA (Affi  -BmpA) or BmpB (Affi  -
BmpB) antibodies. The arrowhead and arrow indicate the positions of 
BmpA and BmpB, respectively. (B) BmpA or BmpB antibodies bind the 
surface of intact unfi  xed   B. burgdorferi   (arrows). Spirochetes were immo-
bilized on glass slides and probed with affi  nity-purifi  ed BmpA (Affi  -
BmpA), BmpB (Affi  -BmpB) antibodies, or normal rabbit sera (NRS). Images 
were acquired using the 40  ×   objective lens of an epifl  uorescence micro-
scope (Axiovert 200M; Carl Zeiss, Inc.). Bars, 10   μ  m. (C) Borreliacidal activ-
ities of BmpA or BmpB antibodies in vitro  .   Spirochetes were incubated 
with normal rabbit sera (NRS), affi  nity-purifi  ed BmpA (Affi  -BmpA), BmpB 
(Affi  -BmpB), or rabbit OspA antibodies (OspA). The number of viable spiro-
chetes was assessed by fl  uorescent microscopy after labeling the spiro-
chete preparations with vital dyes at 48 h of incubation. Data represent 
the mean number of viable spirochetes/microscopic fi  eld after antibody 
incubation   ±   the SEM from three independent experiments. The number 
of viable spirochetes exposed to the affi  nity-purifi  ed BmpA or BmpB anti-
bodies were signifi  cantly diminished compared with spirochetes that 
received NRS.   n   = 3. P   <   0.01. As expected, OspA antisera resulted in the 
complete killing of   B. burgdorferi .   
    Figure 3.         Affi  nity-purifi  ed Bmp antibodies most dramatically affect 
  B.       burgdorferi persistence in mouse   joints.    Affi  nity-purifi  ed BmpA 
or B antibodies interfere with the persistence of   B. burgdorferi   in  joints. 
Mice (15 animals/group) were infected with   B. burgdorferi   and  adminis-
tered affi  nity-purifi  ed BmpA (Affi  -BmpA), BmpB (Affi  -BmpB), or control 
GST antibodies. The   B. burgdorferi   level in mouse tissues was assessed by 
measuring   fl  aB   copies at days 15 and 18 after   B. burgdorferi   infections, 
and it is expressed as   fl  aB /mouse    b -actin  . The   B .   burgdorferi   load in joints 
and skin of mice receiving BmpA or BmpB antibodies was signifi  cantly 
lower than in mice receiving control GST sera.   n   = 3. P   <   0.01  –  0.001. Bars 
represent the mean   ±   the SEM from two independent experiments and the 
spirochete burden of the control mice was considered as the 100% value.     4 of 9 ROLE OF   BORRELIA   BMPA/B PROTEINS IN LYME ARTHRITIS | Pal et al.
the wild-type spirochetes (unpublished data). Because   bmpA/B        
B. burgdorferi   were as infectious as the isogenic wild-type spiro-
chetes in the mice, we assessed whether BmpA and BmpB were 
required for   B. burgdorferi   to eff  ectively colonize mouse joint 
tissue. The spirochete loads were analyzed in joints or in control 
tissue locations (skin and bladder) 14 and 18 d after   B. burgdorferi   
infection. qPCR indicated that   bmpA/B        B. burgdorferi   were 
not detected in joints, but were evident in the skin and bladder 
tissue at all time points, such as day 14 or 18 (unpublished 
data) after infection. Severe joint swelling developed in mice in-
fected with wild-type   B. burgdorferi  , but not in animals infected 
with   bmpA/B        B. burgdorferi  . Collectively, these data suggest 
that BmpA and BmpB may be essential for   B. burgdorferi   to 
colonize joints and induce Lyme arthritis. 
  Complementation restores the ability of   bmpA/B        
B. burgdorferi   to colonize joints and cause arthritis 
  To exclude the possibility that the failure of the   bmpA/B        
B. burgdorferi   to persist within joints was caused by an anoma-
lous eff  ect of transformation, we complemented, in trans, the 
from neighboring gene loci, such as   bb0381  ,   bmpC  , and   bmpD.   
The protein profi  les of the   bmpA/B          spirochetes and the wild-
type organisms were identical (  Fig. 4 C  , left), except that the 
  bmpA/B        B. burgdorferi   did not produce BmpA (  Fig. 4 C  , top 
right) or BmpB protein (  Fig. 4 C  , bottom right). 
  We then compared the infectivity between   bmpA/B        
B. burgdorferi   and the wild-type spirochete in vivo using the 
mouse model of Lyme borreliosis. In nature, ticks transmit 
  B. burgdorferi   infection to mammals; however, to ensure an iden-
tical inoculation dose of wild-type and mutant spirochetes in 
the mouse host, we infected mice with a needle inoculum con-
taining a specifi  c amount of   B. burgdorferi  . Groups of 10 C3H/
HeN mice were inoculated intradermally on the hind legs 
with 10  4   wild-type or   bmpA/B        B. burgdorferi  . Both wild-type 
and mutant spirochetes were readily cultured from skin, and 
qPCR of mouse skin biopsy (ear) specimens or blood (  Fig. 4, 
D and E  ) collected 1 wk after infection showed similar patho-
gen levels  .   When ticks were allowed to engorge on mice in-
fected with   bmpA/B        B. burgdorferi  , the mutant spirochetes 
were able to migrate into fed ticks, albeit at a lower level than 
    Figure 4.         Construction and analysis of the   bmpA/B    —      B. burgdorferi      . (A) Schematic drawings of the wild-type isolate (WT) and the   bmpA/B   —     mutant  at 
the   bmpAB   locus. Genes   bb0381 ,   bmpB ,   bmpA ,   bmpC  , and   bmpD   (white box-arrows) and the kanamycin-resistance cassette driven by the   B. burgdorferi fl  aB   
promoter (fl  aB-Kan, black box-arrow) are indicated. Nucleotide positions of primers P1-P4 in the   B. burgdorferi   genomic database (www.tigr.org) are indicated 
within parentheses. The 5     and the 3     arms for homologous recombination, fl  anking up- and downstream of the   bmpAB   locus were amplifi  ed using primers 
P1-P2 and P3-P4 and ligated to the fl  aB-Kan cassette, as detailed in the Materials and methods. (B) RT-PCR analysis of the   bmpA   and   B   transcripts. Total RNA 
were isolated from either the wild-type (WT) or mutant (  bmpA/B   —  ) B. burgdorferi,   converted to cDNA, and subjected to PCR analysis with   fl  aB ,   bmpA ,   bmpB, 
bmpC  , or   bmpD   primers and analyzed on a 2% agarose gel. (C) Protein analysis of wild-type (WT) or   bmpA/B   —     spirochetes. Equal amounts of proteins from 
wild-type or   bmpA/B   —   B. burgdorferi   were separated on a SDS-PAGE gel, and either stained with Coomassie blue (left) or transferred onto a nitrocellulose 
membrane and probed with the affi  nity-purifi  ed BmpA (top right) or affi  nity-purifi  ed BmpB (bottom right) antibody. Migration of protein standards is shown 
to the left in kilodaltons. (D) Comparable levels of wild-type and   bmpA/B   —   B. burgdorferi   in the dermis of infected mice. Total DNA was isolated from the skin 
of mice 1 wk after   B. burgdorferi   challenge. The   B. burgdorferi   burden was analyzed by qPCR measurement of   fl  aB   copies and expressed as   fl  aB /mouse 
   b -actin  . Wild-type (WT) and   bmpA/B   —   B. burgdorferi   were evident in similar numbers.   n   = 3. P   >   0.5. (E) The   bmpA/B   —   B. burgdorferi   were capable of dissemina-
tion from the dermis of infected mice. Blood was collected from mice 1 wk after   B. burgdorferi   challenge, and spirochete burden was analyzed by qPCR 
measurement of   fl  aB   copies and expressed as   fl  aB /mouse    b -actin  . Similar levels of wild-type (WT) and   bmpA/B   —   B. burgdorferi   were detected.   n   =  3.  P   >   0.5.   JEM 
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  We then characterized the ability of the complemented 
spirochetes to establish infection and induce joint infl  amma-
tion in mice. Groups of 10 C3H/HeN mice were inoculated 
intradermally in the hind legs with 10  4   wild-type spirochetes, 
mock-complemented   bmpA/B       B. burgdorferi  , or  bmpAB-  com-
plemented   bmpA/B        B. burgdorferi  . The spirochete burden in 
the joint, bladder, or skin (ear) tissues and the joint swelling 
were evaluated 14, 21, and 28 d after   B. burgdorferi   infection. 
The   bmpA/B          mutant and the complemented isolates all readily 
colonized the bladder and skin tissues. Although the   bmpA/B          
mutant was not detected in the joints, the   bmpAB-  comple-
mented   B. burgdorferi   were able to persist in the joints at all times 
during peak infection, between days 14  –  21, albeit at lower lev-
els than wild-type isolates (  Fig. 5 C  ). At day 28, as the host im-
mune response controlled the spirochete load, the   B. burgdorferi   
levels in all tissues declined signifi  cantly. Joint swelling was 
  bmpA/B          spirochetes with a wild-type copy of the   bmpA   and 
  bmpB   gene under the control of native promoter. To con-
struct complemented isolates of   B. burgdorferi  , we transformed 
the mutant with the recombinant shuttle plasmid pKFSS1 car-
rying a wild-type copy of the   bmpA   and   bmpB   gene (  Fig. 5 A  ) 
placed upstream of a streptomycin-resistance gene.   As controls 
for the complementation experiments, additional mock-
complemented isolates were also constructed by transforming 
the wild-type spirochetes and   bmpA/B        B. burgdorferi   with the 
empty pKFSS1vector. PCR analysis confi  rmed that, similar 
to the wild-type   B. burgdorferi  , the mock-complemented 
and   bmpAB  -complemented spirochetes retained all of the 
  B. burgdorferi   plasmids (unpublished data). Immunoblotting 
showed that the   bmpAB  -complemented mutant, but not the 
mock-complemented mutant, produced both BmpA and BmpB 
protein (  Fig. 5 B  ). 
    Figure 5.     Complementation of   bmpA/B    —        B. burgdorferi     with             bmpA   and   bmpB   restores the ability of spirochetes to survive in joints and 
induces greater levels of arthritis.   (A) The   bmpA   and   B   gene, including its native promoter region was amplifi  ed and cloned into the shuttle vector 
pKFSS1 and transformed into the   bmpA/B   —     spirochetes. (B) Western blot demonstrates production of the BmpA and BmpB proteins by the complemented 
  B. burgdorferi  . Equal amounts of proteins from the mock-complemented   bmpA/B   —     spirochetes  ( bmpA/B   —    ), mock-complemented wild-type (WT), or com-
plemented spirochetes (  bmpAB   Com) were separated on a SDS-PAGE gel, which was either stained with Coomassie blue (left) or transferred to nitro-
cellulose membrane. Individual Bmp proteins were probed with the affi  nity-purifi  ed BmpA (top right) or BmpB (bottom right) antibodies. (C) The 
  B. burgdorferi   burden in mice infected with mock-complemented wild-type (gray bar), mock complemented   bmpA/B   —     mutant (black bar), and   bmpA/B   —     mu-
tant complemented with   bmpA   and   bmpB   (white bar). Groups of mice (10 animals/group) were infected with wild-type or genetically manipulated iso-
lates of   B. burgdorferi  , and the spirochete burden was analyzed at day 14, 21, and 28 by measuring copies of the   B. burgdorferi fl  aB   gene. Amounts of 
mouse    b -actin   were determined in each sample and used to normalize the quantities of spirochete DNA. Mutant or complemented spirochete levels in 
the bladder and skin (ear) tissue were similar.   n   = 3. P   >   0.5. Levels of   bmpAB   complemented isolates were signifi  cantly higher in the joints than   bmpA/B   —    
mutants. Error bars represent the mean   ±   the SEM of relative tissue levels of   B. burgdorferi .   n   = 3. *, P   <   0.05. (D) Severity of joint swelling in   B. burgdor-
feri –   infected mice. Groups of mice (10 animals/group) were separately infected with mock complemented wild-type   B. burgdorferi   (gray bar), mock 
complemented   bmpA/B   —     mutant (black bar), and   bmpA/B   —     spirochetes complemented with   bmpA   and   bmpB   gene (white bar). Arthritis was evaluated by 
the assessment of development of joint swelling after 14, 21, and 28 d of spirochete challenge using a digital caliper. Bars represent the mean measure-
ments (  ±   the SEM) from three independent experiments. Signifi  cant differences in the infl  ammation level were noticed between groups of mice infected 
with wild-type isolates with the   bmpA/B   —     mutant at all time points. **, P   <   0.001 - 0.04. Highly signifi  cant differences between joint infl  ammation was 
also noted in groups of mice infected with   bmpA/B   —     spirochetes and   bmpA/B   —     spirochetes complemented with   bmpAB   at day 21. **, P   <   0.001.     6 of 9 ROLE OF   BORRELIA   BMPA/B PROTEINS IN LYME ARTHRITIS | Pal et al.
studies. The current experiments conclusively demonstrate that 
loss of both   bmpA   and   bmpB   infl  uence the selective survival of 
spirochetes in joints and severely impeded the development of 
infl  ammation. Complementation of the   bmpA/B        B. burgdorferi   
with both   bmpA   and   bmpB   partially reconstituted the wild-type 
arthritis phenotype, further supporting a role for both   B  mpA 
and   B  mpB in Lyme arthritis. Diff  erences between the comple-
mented and wild-type spirochetes could be caused by the ex-
pression of   bmpA/B   on a shuttle vector in the complemented 
isolate, rather than from their native position on the   B. burgdorferi   
chromosome, among other possibilities. 
  We have also examined several human samples to extend our 
observations beyond mice.   bmpA   and   bmpB   levels were mea-
sured in skin biopsies from fi  ve patients with early Lyme disease 
and   erythema migrans,   and synovial fluid from four patients 
with acute Lyme arthritis. qRT-PCR showed signifi  cantly 
higher levels (P   <   0.03  –  0.009) of   bmpA   and   bmpB   expression 
per spirochete in the synovial fl  uid compared with the skin. 
In the joints, 21.4   ±   10.8 ng   bmpA  /ng   fl  aB   was noted compared 
with 0.36   ±   0.2 ng   bmpA  /ng   fl a B    in the skin. Similarly, 11.0   ±   
3.0 ng   bmpB  /ng   fl a B    was present in the joints, compared with 
0.34   ±   0.17 ng   bmpB  /ng   fl a B    in the skin. We recognize that 
the skin and joint samples come from diff  erent patients; however, 
simultaneous skin and joint specimens from the same pa-
tient are rarely, if ever, obtained. Moreover, the spirochete 
in each sample may not be identical, even though the vast 
majority of organisms in the New York/Connecticut region are 
  B. burgdorferi   sensu stricto. Nevertheless, these data provide a 
fi  rst suggestion that our mouse data may be applicable to human 
disease as well. 
  In nature,   B. burgdorferi   survives in an enzootic cycle where 
immature ticks acquire the pathogen from wild rodents, and 
then maintain   B. burgdorferi   and subsequently transmit the spi-
rochetes back to mice (  3  ). As the tick bite site is primarily lo-
cated in the mouse dermis, the population of   B. burgdorferi   that 
persistently resides in skin is most likely to complete the tick  –
  mouse  –  tick life cycle, and should have a selective advantage 
in nature. The adaptive signifi  cance of dissemination of spiro-
chetes to deeper host organs (  37  ), such as the joints, where 
they are unlikely to be acquired by ticks, is not clear, although 
certain sites may aff  ord survival advantages because of protec-
tion from host responses, binding ligands, or nutrients present 
in the microenvironment. 
  Lyme arthritis is the direct result of a localized host in-
fl  ammatory response (  1  ), presumably against antigens that are 
abundant on the surface of the invading spirochete. Joint-in-
duced, surface-exposed, and highly antigenic   B. burgdorferi   
proteins, such as BmpA and B could potentially initiate the 
complex cascade of host infl  ammatory responses that lead to 
arthritis. However, as the spirochete is coated with many 
proinfl  ammatory lipoproteins, it is more likely that BmpA 
and B have a role in spirochete survival in the joints, and that 
the lack of arthritis in the   bmpA/B        B. burgdorferi   is caused by the 
inability of these spirochetes to colonize and persist in joint 
tissue. In summary, we present direct evidence for a dynamic 
transcriptome of   B. burgdorferi   in vivo and show that diff  erentially 
minimal in mice infected with the   bmpA/B        B. burgdorferi   at 
7, 14, 21, or 28 d, demonstrating that the kinetics of joint 
disease development was abrogated, and not merely delayed, 
in mice infected with the mutant. In agreement with earlier 
observations (  14, 24  ), wild-type   B. burgdorferi   induced severe 
ankle swelling that is most dramatic at day 21 and is consistent 
with histopathological signs of arthritis (  Fig. 5 D   [P   <   0.001] 
and Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20070962/DC1). Joint inflammation in   bmpAB-
  complemented   bmpA/B    —    B. burgdorferi  -infected mice were 
lower than that induced by the wild-type spirochetes, however, 
at the peak period of joint infl  ammation, day 21, the   bmpAB-
  complemented isolates induced signifi  cantly higher swelling 
of the joints compared with   bmpA/B        B. burgdorferi   (  Fig. 5 D   
[P   <   0.001] and Fig. S1). 
    DISCUSSION   
    B. burgdorferi   alters its gene expression profi  le as it cycles between 
arthropods and mammals (  29, 30  ), and specifi  c genes help 
maintain the spirochete in nature (  20, 24, 31  –  35  ).   I. scapularis   
ticks, while feeding on a mammalian host, deposit a hetero-
geneous population of   B. burgdorferi   in the dermis (  36  ), which 
eventually spread to multiple organs (  2  ). Selected   B. burgdorferi   
genes may be preferentially expressed in diff  erent locations 
(  22  ); however, it is not known if the gene products that are 
induced in tissues can directly contribute to disease. We show 
that both genes of the   B. burgdorferi bmpA/B   operon undergo 
selective up-regulation in mouse joints (  37  ), and that the 
targeted deletion of   bmpA/B   specifi  cally decreases   B. burgdorferi   
persistence in this tissue. 
  Immune sera from a   B. burgdorferi  –    infected host (  38, 39  ), or 
specifi  c antisera (  40  –  42  ), is protective when administered be-
fore spirochete challenge. The same antisera does not eradicate 
  B. burgdorferi   when transferred after challenge, but can modu-
late arthritis (  39  ), showing that the borreliacidal and disease-
modifying components in immune sera are diff  erent. Antisera 
against ubiquitously expressed spirochetal antigens, such as Arp 
(  15, 16, 43  ) and DbpA (  43  ), can modify arthritis with no eff  ect 
on spirochete levels in tissues. Functions of BmpA and BmpB 
proteins in the   B. burgdorferi   natural cycle, and their correlation 
with the induction of arthritis, are currently unknown. In our 
study, both BmpA and BmpB antisera most dramatically inhib-
ited the colonization of spirochetes in the joints, and to a lesser 
extent, in the skin, but not in other tissues. Although BmpA, 
DbpA, OspC, and FlaB antibodies have been identifi  ed in im-
mune sera that has arthritis-resolving properties (  12, 39  ), the 
passive transfer of BmpA antisera did not previously infl  uence 
the genesis of arthritis (  39  ). Diff  erences in study design, spiro-
chete isolates, such as N40 versus B31, used in the current ex-
periments, or the quality of the antisera can potentially infl  uence 
such results. Although the N40 isolate has been well known for 
its capability to induce arthritis in mice (  12, 39  ), the limited ge-
nomic information on this isolate compared with B31 (  25  ), and 
more importantly, the extreme diffi   culties in the genetic trans-
formation of N40 (  44  ), makes B31 preferable for these genetic JEM 
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  Protein expression and preparation of affi   nity-purifi  ed  polyclonal 
antibody.     Recombinant BmpA and BmpB proteins were produced in   E. coli   
using the bacterial expression vector pGEX-6P1 (GE Healthcare). The list of 
primers used for directional cloning of Bmp proteins (without the N-terminal 
leader sequence) is indicated in Table S1. Expression, purifi  cation, and enzy-
matic cleavage of the GST fusion proteins were performed as previously de-
scribed (  48  ). To generate polyclonal antisera, BmpA or BmpB (without the 
GST tag) produced in   E. coli   was emulsifi  ed in complete Freund  ’  s adjuvant and 
injected into groups of 2  –  3 rabbits (100   μ  g/animal). The animals were boosted 
twice at 3 wk intervals with the same dose of antigen in incomplete Freund  ’  s 
adjuvant, and the sera were collected 2 wk after the second boost. Respective 
cross-reactivity of the BmpA or BmpB polyclonal antibodies against BmpB or 
BmpA were removed using the previously described affi   nity purifi  cation ap-
proach (  28  ), with the following modifi  cations. Recombinant BmpB (rBmpB) 
was expressed with a GST fusion protein, as described in this section, and 
bound to a Sephadex 4B column (GE Healthcare) according to the manufac-
turer  ’  s instructions. The column was washed with 10 bed volumes of PBS. To 
purify BmpA antibody, the antisera was diluted fi  vefold in PBS and cycled 
over the rBmpB-bound column by gravity fl  ow for 5 cycles of 10 passages 
each, for a total of 50 passages. BmpB antibody was also purifi  ed in a similar 
fashion by passing the diluted antisera through rBmpA-bound column. 
  Characterization of antibody in vitro.     Affi   nity-purifi  ed BmpA and BmpB 
antibodies were tested for their bactericidal activity using a combination of two 
vital stains that specifi  cally label live and dead spirochetes, as previously de-
scribed (  49  ). In brief, spirochetes (5   ×   10  7  /ml) were incubated in 15   μ  l BSK-H 
medium (Sigma-Aldrich) with the addition of equal volume of normal rabbit 
sera or purifi  ed Bmp antibodies for 48 h at 33  °  C. Spirochetes were labeled 
with the live/dead   Bac  Light Viability kit (Invitrogen) according to manufactur-
er  ’  s instructions. Bactericidal activities of the antiserum were determined by 
counting the number of live and dead spirochetes from 10 random microscopic 
fi  elds under high magnifi  cation, as previously described (  49  ). Bactericidal rab-
bit antiserum against   B. burgdorferi   OspA was used as a control in the assay. 
  Antibody binding to unfi  xed   B. burgdorferi   was assessed by immuno-
fl  uorescence microscopy, as previously described (  32  ). Spirochetes (10  7  /ml) 
were spotted on silylated glass slides (PGC Scientifi  c), blocked with PST (0.05% 
Tween-20, 5% normal goat sera in PBS), and incubated with normal rabbit sera 
or affi   nity-purifi  ed BmpA or BmpB antibodies (1:500 dilution in PST). Samples 
were similarly incubated with secondary FITC-labeled goat anti  –  rabbit anti-
body (KPL) at a dilution of 1:100, and spirochetes were visualized using an epi-
fl  uorescence microscope (Carl Zeiss, Inc.). 
  Western blotting was performed as previously described (  48  ) using 
1:5,000 dilutions of either of the affi   nity-purifi  ed BmpA or BmpB antibody 
and HRP-conjugated anti  –  rabbit secondary antibody (Sigma-Aldrich). 
  In vivo antibody-blocking studies.     In brief, C3H/HeN mice were 
infected with   B. burgdorferi   B31 (10  5   spirochetes/mouse) for 3 d and affi   nity 
purifi  ed Bmp or control (GST) antibodies were administered to groups of mice 
(15 animals/group, 100   μ  l antibody/mouse). To maintain eff  ective concen-
trations of the antibody, the animals were treated with the respective antibody 
every 3 d for 2 wk. Parallel control studies confi  rmed that similar treatment of 
naive C3H mice with rabbit anti-BmpA/B sera do not result in joint pathol-
ogy, as indicated by the assessment of arthritis at 2 and 4 wk after the initiation 
of antibody treatment (unpublished data). The mice were killed 12, 15, and 
18 d after   B. burgdorferi   infections, and skin, heart, joint, and bladder samples 
were isolated and stored at   –  80  °  C.   B. burgdorferi   burdens in tissues samples 
were measured by qPCR analysis, as described in PCR. 
  Evaluation of joint infl  ammation.       B. burgdorferi    –  infected mice were ex-
amined for swelling of the tibiotarsal joints, as previously detailed (  12, 50, 51  )  .   
Ankle joints from each of the rear legs of each mouse were measured using a 
precision metric caliper in blinded fashion. Thickest diameters of the tibiotar-
sal joints were measured in each mouse before   B. burgdorferi   infection, and the 
development of infl  ammation was monitored and tabulated on a weekly basis 
until the sacrifi  ce of the mice. At least 5 ankle joints from each group of mice 
up-regulated genes, such as   bmpA   and   bmpB   in the joints, play 
a role in spirochete persistence in a specifi  c host environ-
ment. This information contributes to our understanding 
of the adaptive strategies of a pathogen that is able to sur-
vive in numerous tissues, and may lead to new ways to mod-
ulate Lyme arthritis. 
    METERIALS AND   METHODS 
    B. burgdorferi   and mice.     A low passage (passage 3) virulent isolate of 
  B. burgdorferi   B31, clone 5A11, was used throughout this study (  45  ). Mice were 
infected with a single inoculum of 10  4    –  10  5   spirochetes/mouse by intrader-
mal injection to the hind leg. 4  –  6-wk-old C3H/HeN mice were purchased 
from the National Institutes of Health. All animal procedures were per-
formed in compliance with the guidelines and with the approval of the Insti-
tutional Animal Care and Use Committee. 
  Selective amplifi  cation of   B. burgdorferi   RNA and microarray analysis.   
  Whole-genome nylon membrane arrays containing 1,697 putative ORFs 
encoded by   B. burgdorferi   B31 were used in this study (  46  ). Selective am-
plifi  cation of   B. burgdorferi   transcripts in the infected mouse host was per-
formed using the DECAL approach, as previously detailed (  22, 47  ). Groups 
of C3H/HeN mice (10 mice/group) were injected with   B. burgdorferi   (10  4    –  10  5   
spirochetes/mouse), and spirochetal infection was confi  rmed by PCR and 
culture (  35  ). The mice were killed 15 d after spirochete inoculation, and to-
tal RNA was isolated from distal skin, joints (tibiotarsal), heart, and urinary 
bladder using the RNeasy RNA isolation kit (QIAGEN) as described by the 
manufacturer. 1 mg of total RNA was reverse transcribed into biotinylated 
cDNA using random hexamer primers, biotin-dNTP, and the SuperScript 
First Strand synthesis system (Invitrogen). Positive selection and amplifi  ca-
tion of spirochete transcripts was performed according to a published method 
(  22  ), and the PCR products representing amplifi  ed   B. burgdorferi   mRNAs 
(skin-DECAL, joint-DECAL, heart-DECAL, and bladder-DECAL) were 
normalized using   fl a B   -specifi  c primers and labeled with a random priming 
method using FITC-labeled dNTPs (GE Healthcare). The labeled probes 
were further normalized based on their hybridization intensity to equal 
amounts of   fl a B    PCR products blotted onto nylon membrane (unpublished 
data). The normalized probes were then used to hybridize duplicate micro-
arrays using RapidHyb buff  er (GE Healthcare) according to the manufactur-
er  ’  s instructions. After probing the arrays with DECAL-labeled cDNAs, the 
hybridization was scored visually, and spots were given a score ranging from 
0 to 3 (in increments of 0.5) based on the intensity of hybridization, as previ-
ously described (  22  ). A spot was considered positive when a minimum of 
twofold increase in hybridizations was noted (in joint), in comparison to 
similar spot hybridizations in other tissues (in skin, heart, and bladder). 
  PCR.     The nucleotide sequence of various primers used in specifi  c PCR 
applications is indicated in Table S1 (available at http://www.jem.org/cgi/
content/full/jem.20070962/DC1). RT-PCR or qRT-PCR analysis was 
performed as previously described (  48  ) using iQ SYBR Green Supermix 
(Bio-Rad Laboratories) or using TaqMan probes synthesized by Applied 
Biosystems. All probes contained a 5     reporter (FAM) and a 3     quencher 
(TAMRA). The amounts of   B. burgdorferi bmp   transcripts in each sample were 
normalized to levels of   fl a B    transcripts in qRT-PCR reactions. For quantita-
tive detection of   B. burgdorferi   burdens within mouse tissue samples, qPCR 
was performed on an equal amount of isolated DNA using fl  agellin (  fl a B   ) as a 
surrogate marker (  35  ). The mouse       -actin   gene was amplifi  ed to normalize the 
amount of   B. burgdorferi   cDNA in the qPCR reaction. Skin biopsy specimens 
from fi  ve patients with   erythema migrans  , and synovial fl  uid from four patients 
with acute Lyme arthritis, were obtained at New York Medical College and 
Yale University School of Medicine. Skin biopsy specimens were immedi-
ately placed in RNALater (Ambion) and stored at     80  °  C; synovial fl  uid sam-
ples were rapidly frozen and stored at     20  °  C. Human samples were processed 
for cDNA synthesis and used for qRT-PCR, as described in this section. 8 of 9 ROLE OF   BORRELIA   BMPA/B PROTEINS IN LYME ARTHRITIS | Pal et al.
  Statistical analysis.     Results are expressed as the mean   ±   the SEM. The sig-
nifi  cance of the diff  erence between the mean values of the groups was evalu-
ated by Student  ’  s   t   test with StatView software (SAS Institute). 
  Online supplemental material.     Histological images of the ankle joints of 
mice infected with the wild-type   B. burgdorferi  ,   bmpA/B   mutant and   bmpAB   
complemented isolates are shown in Fig. S1. The online version of this article 
is available at http://www.jem.org/cgi/content/full/jem.20070962/DC1. 
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(10 animal/group) infected with the diff  erent strains were subjected to histo-
logical analyses. 20 randomly chosen sections from each of the mouse groups 
were assessed for histopathological comparisons. For histology, joints were 
fi  xed in 10% formalin, decalcifi  ed, and processed for hematoxylin and eosin 
staining. Overall signs of arthritis represented a combined assessment of histo-
logical parameters of   B. burgdorferi  –    induced infl  ammation, such as exudation of 
fi  brin and infl  ammatory cells into the joints, alteration in the thickness of ten-
dons or ligament sheaths, and hypertrophy and hyperlexia of the synovium. 
  Generation and phenotypic analysis of   bmpA/B   mutant and genetic 
complementation of   B. burgdorferi.       The oligonucleotide primers used for 
genetic manipulation of   B. burgdorferi   are indicated in Table S1. The   bmpA/B   
mutant was constructed by exchanging the upstream of   bmpA/B   operon with 
a kanamycin-resistance cassette from the plasmid pXLF10601 (  45  ) via homol-
ogous recombination. First, the 5     and the 3     arms fl  anking   bmpA   ORF (open 
reading frame) were PCR-amplifi  ed using primers P1-P4 and cloned into two 
multiple-cloning sites fl  anking the kanAn cassette in plasmid pXLF10601. 
Plasmid DNA of pXLF10601-bmpAB (30   μ  g) was electroporated into 
  B. burgdorferi   B31 clone 5A11 using the previously described protocol (  45  ). 
Transformants were selected in BSK-H complete medium (Sigma-Aldrich) 
containing kanamycin (350   μ  g/ml). Spirochetes that survived antibiotic selec-
tion were further analyzed by PCR to confi  rm the desired integration of 
kanAn cassette, and all known endogenous plasmids that are present in parental 
B31 isolate were also assessed in the mutant clones, as previously described (  32  ). 
One of the   bmpA/B   knockout clones that retained the same complete set of 
plasmids as the wild-type isolate was used in further experiments. 
  For genetic complementation of the   bmpA/B   mutant, we used the 
  B. burgdorferi   shuttle plasmid pKFSS1 (  52  ) to deliver the wild-type copy of the 
  bmpA   and   bmpB   gene. The DNA fragment encompassing   bmpA   and   bmpB   gene 
and the native promoter (  26  ) were PCR-amplifi  ed using primers (Table S1) 
and cloned into the   BamHI   and   SalI   sites of pKFSS1. 20     g of the recombinant 
plasmid, designated pKFSS1-pbmpAB, were electroporated into the   bmpA/B        
B. burgdorferi  , and complemented clones were selected using 50   μ  g/ml of 
streptomycin in the growth medium. As appropriate controls for comple-
mentation studies, additional mock-complemented isolates were also gener-
ated by transformation of the wild-type   B. burgdorferi   and   bmpA/B        
B. burgdorferi   with the empty vector pKFSS1. PCR analyses were further 
performed to confi  rm that the mock or the   bmpAB-  complemented clones 
contained the respective plasmids, either the empty vector or pKFSS1-pbmpAB 
and also retained the same plasmid profi  le as the wild-type as described in the 
previous paragraph. 
  For phenotypic analysis of mock-complemented   bmpA/B   mutants and 
  bmpAB-  complemented isolates in vivo,   B. burgdorferi   isolates were injected 
into groups of mice (10 animals/group) via needle inoculation (10  4   spiro-
chetes/mouse) intradermally on the hind legs. For effi   cient maintenance of 
the shuttle plasmid in vivo, the mice were injected with streptomycin (300   μ  g/
animal) every 2 d after the spirochetal inoculum and until the sacrifi  ce of the 
animals. Separate experiments indicated that the injected doses of streptomy-
cin do not interfere with   B. burgdorferi   pathogenicity or infectivity in mice 
(unpublished data). For tick acquisition studies, groups of mice (5 animals/
group, 20 ticks/mouse) were allowed to be fed by naive ticks after 1 wk of   B. 
burgdorferi   infection, as previously described (  48  ). The ticks were allowed to 
feed to repletion and detach from the mice, which usually occurred between 
72  –  96 h. Immediately after engorgement, fed ticks were analyzed for qRT-
PCR measurement of   bmp   expression or   B. burgdorferi   burden, as detailed earlier. 
Guts from parallel group of nymphs were also dissected under a micro-
scope in PBS (  20   μ        l  /  gut) after engorgement, and analyzed for BmpA and BmpB 
localization in wild-type spirochetes using immunofl  uorescence studies with 
specifi  c Bmp antibodies as described above. For mutagenesis studies, mice 
were killed at day 14 and 18, and for complementation experimentation the 
mice were killed 14, 21, and 28 d after the initial inoculum. Joint, skin (ear), 
and bladder samples were isolated from infected mice, and   B. burgdorferi   
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